Background: Paramyosin is a thick myofibrillar protein found exclusively in invertebrates. Evidence suggested that paramyosin from helminths serves not only as a structural protein but also as an immunomodulatory agent. We previously reported that recombinant Trichinella spiralis paramyosin (Ts-Pmy) elicited a partial protective immunity in mice. In this study, the ability of Ts-Pmy to bind host complement components and protect against host complement attack was investigated.
Introduction
Trichinellosis is one of the common parasitic zoonoses and is a serious public threat in both developing and developed countries [1] [2] [3] [4] [5] [6] . Trichinella spiralis (T. spiralis) infection is initiated by the consumption of meat contaminated with infective muscle larvae (ML). With the aid of host gastric juice, ML are released from cysts and migrate to the small intestine where they develop into adult worms in 2-3 days. Five days post-infection, gravid females begin to produce newborn larvae (NBL), which penetrate the intestinal mucosa and enter the lymphatic vessels and bloodstream [7] . NBL travel through capillaries to various organs and finally invade the muscles, where they form cysts. During the life cycle of T. spiralis in the host, all developmental stages are exposed to host complement, which is the first line of defense against pathogenic organisms and is a functional bridge between the innate and adaptive immune responses [8] .
The ability to evade complement attack is essential for the survival of parasites within their respective hosts [9] . As early as 1911, the presence of complement-fixing antigens from larvae of T. spiralis was reported in antiformin extracts of pepsin-digested rat muscle [10] . Complement -fixing antigens have since been used to diagnosis of trichinosis of trichinellosis [11, 12] . Subsequent studies have reported that the complement elements C3, C5 [13] , C1q, C8 and C9 [14, 15] directly bind the ML of T. spiralis. All three stages of T. spiralis are capable of activating complement via the classical or alternative pathways [14] , or the lectin pathway [16] . However, it is still unknown whether the activation of the complement is detrimental or beneficial to the parasite. NBL might be the most potent activators [13] . Molecules or structures on the outermost cuticle/epicuticle of the parasite directly bind complement and appear to protect the parasite from an attack by inhibiting the formation of the membrane attack complex (MAC) [14, 15] . Rats with normal levels of C6 or those with a C6-deficiency have similar susceptibilities to infection by T. spiralis. However, C3, C8 and C9 were found to bind worms, suggesting that T. spiralis has efficient mechanisms for protecting against complement attack [15] . However, the precise molecular basis for this resistance is still unknown.
Paramyosin is a thick myofibrillar protein found exclusively in invertebrates [17] . Experimental evidence has shown that paramyosin from helminths serves not only as a structural protein but also as an immunomodulatory agent [18] [19] [20] [21] [22] . It has been reported that paramyosin from Taenia solium inhibits C1 function [18] . Paramyosin from Schistosoma mansoni acts as an immunological defense molecule by binding C1q [18] , the Fc fragment of IgG [19] , C8 and C9 [20] [21] . Recently, paramyosin from Clonorchis sinensis was shown to bind both human collagen and C9 [22] . In our previous study, a full-length cDNA encoding T. spiralis paramyosin (Ts-Pmy) was cloned by immunoscreening an adult T. spiralis cDNA library with infected immune sera [23] , Recombinant Ts-Pmy (rTs-Pmy) elicited partial protective immunity against a T. spiralis larval challenge in BALB/c mice [24] . In the present study, we investigated ability of rTs-Pmy to bind to host complement components and to protect against host complement attack. Our data show that rTs-Pmy binds complement components C8 and C9 and inhibits the complement-mediated killing of NBL, providing more evidence that Ts-Pmy plays an important role in the evasion of the host immune response to facilitate the survival of T. spiralis in its host.
Materials and Methods

Animals
All experimental animals were purchased from Laboratory Animal Services Center of Capital Medical University (Beijing, China). All experimental procedures were reviewed and approved by the Capital Medical University Animal Care and Use Committee and were consistent with the NIH Guidelines for the Care and Use of Laboratory Animals.
Parasites and antigen preparation
T. spiralis (ISS 533 strain) was maintained in female ICR mice. ML were recovered from the muscles of infected mice by a standard pepsin/hydrochloric acid digestion method as described previously [14] . Adult worms were obtained from the intestine of a rat infected orally with 800 T. spiralis ML [25] . NBL were obtained from fertile female adult worms cultured overnight in RPMI 1640 at 37uC. Crude somatic extracts of the different stages of T. spiralis were prepared by conventional methods [26] , and the protein concentration was determined by the BCA assay (Pierce,USA).
RT-PCR analysis
Total RNA was extracted from T. spiralis ML, adult worms and NBL with an RNAeasy mini kit (Qiagen, Germany) according to the manufacturer's instructions. Total first-strand cDNAs were reverse transcribed from the total mRNAs using a Sensiscript Reverse Transcription kit (Qiagen, Germany). The specific forward primer (59-ACC AAC TGA GGG CTT TGC A-39) and reverse primer (5-9 AAT ATT CAT GTC CTT CTT CCA TCA C-39), based on Ts-Pmy coding sequence of 1830-2730 bp, were used to amplify Ts-pmy cDNA fragments (900 bp) from reverse transcribed total cDNA from different developmental stages of T. spiralis using a PCR kit (TaKaRa, China). Reactions without the addition of reverse transcriptase were used as negative controls. The amplified products were analyzed in 2% agarose gels and stained with DNA Green (Tandz, USA).
Expression of recombinant paramyosin (rTs-Pmy) and preparation of the anti-rTs-Pmy antibody rTs-Pmy was expressed in E. coli BL-21(DE3) using the pET-28a expression system (Novagen, USA) and purified with Ni-affinity chromatography (Qiagen, USA), as described previously [23] . The antiserum against rTs-pmy was raised in rabbits immunized three times with 150 mg rTs-Pmy. The monoclonal antibody against rTs-Pmy (mAb 7E2) was obtained using a conventional hybridoma technique, and IgG was purified with HiTrap rProtein A affinity columns (Amersham Biosciences, USA; data not shown).
Western blot analysis
Crude somatic extracts of T. spiralis ML, adult worms and NBL were subjected to SDS-PAGE on a 12% acrylamide gel and transferred onto a PVDF membrane (Millipore, USA). After being blocked with a 5% (w/v) skim milk solution in Tris-buffered saline (TBS) containing 0.05% Tween-20 (Sigma, USA) (TBS-T) for 1 hour at room temperature, the membrane was incubated with mAb 7E2 at a concentration of 50-100 ng/mL in TBS-T. Peroxidase-conjugated goat anti-mouse IgG (1:5,000; Sigma, USA) was used as secondary antibody. The reaction was visualized with enhanced chemiluminescence reagent (Pierce, USA) and exposed to a BioMax film (Kodak, USA). In some experiments, the Odyssey two color infrared imaging system was used according to manufacturer's instructions.
Immunolocalization
Immuno-gold labeling and electron microscopy. To examine whether Ts-Pmy was located on the surface of the parasite, the T. spiralis adult worms and NBL were fixed with 5% paraformaldehyde and 0.1% glutaraldehyde in phosphate buffered saline (PBS) for 72 hours at 4u, rinsed four times for 20 min each in PBS and immuno-labeled with mAb 7E2 (1 mg/mL in PBS) and gold-conjugated protein A (15 nm; Zymed Laboratories Inc., USA). Normal mouse serum at the same dilution was used as the control. The immuno-labeled worms were postfixed in 1% osmium tetroxide for 1 hour and dehydrated in a series of alcohol and acetone before being embedded in Araldite and Epon. Ultrathin sections were cut and stained with uranyl acetate and
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Immunofluorescence labeling. To determine if Ts-Pmy is located on the surface of intact worms, whole adult worms and NBL of T. spiralis were incubated with rabbit anti-rTs-Pmy antiserum or normal rabbit serum for 3 hours at 37uC. After being washed three times with RPMI 1640, the worms were treated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Sigma) (1:100 in RPMI 1640) for 1 hour. The worms were washed three times with RPMI 1640 and examined under a fluorescence microscope (Leica, Germany).
Complement-mediated killing of NBL in vitro
A total of 150 NBL released by adult female worms in culture were pretreated with heat-inactivated (56u for 30 min) rabbit antirTs-Pmy serum, the same serum pre-absorbed with rTs-Pmy or heat-inactivated normal rabbit serum (NRS) (2, 20 or 40 mL) in a total volume of 50 mL in a 96-well plate for 1 hour at room temperature. Heat-inactivated rabbit antiserum against Ts87 was used as a non-relevant antibody control (40 mL). Then, 100 mL of freshly pooled normal guinea pig serum (NGS) was added as a complement source into each well, and the incubation was continued for 24 hours in a 5% CO 2 incubator at 37uC. Heatinactivated NGS (INGS) was added as a control. NBL mortality was monitored under an inverted microscope based on motility (The worms without any movement during 30 seconds of observation and total stretch-out were scored as dead) and the fluorescent staining of the DNA-binding dye SYTOX Green (Invitrogen, USA) [27] . Experiments were run in triplicate. Percent mortality was calculated as described elsewhere [21, 28] .
Passive transfer experiments of NBL
To determine the viability of NBL treated with anti-rTs-Pmy serum and NGS, treated NBL were passively transferred into BALB/c mice intravenously. Briefly, 2000 NBL per group were pretreated with 100 mL of heat-inactivated anti-rTs-Pmy rabbit serum, the same serum pre-absorbed with rTs-Pmy or heatinactivated NRS, and incubated with 400 mL of fresh NGS for 12 hours in a 5% CO 2 incubator at 37uC. INGS were used as a control. After being incubated with NGS or INGS, NBL were washed with serum-free RPMI-1640, re-suspended in 0.25 ml of PBS and injected into the lateral tail vein of BALB/c mice (8 mice for each group) as described elsewhere [29] . Muscle larvae burdens were collected and counted on the 26th day after injection [14] .
Hemolytic assay of the alternative complement pathway
Complement-mediated lysis of rabbit erythrocytes (E R ) was performed via the alternative complement pathway as described by Hong et al. [14] . To test whether Ts-Pmy acts as an inhibitor or neutralizer of the complement activated by the alternative pathway, fresh NGS (6%) were pre-incubated with various amounts of rTsPmy (0, 10, 20 or 40 mg) in Mg-EGTA solution (5 mM MgCl 2 , 10 mM EGTA) for 30 min before adding the mixture to fresh, washed E R ( 3610 8 ) in 0.1 mL of GVB (Veronal-buffered saline, pH 7.4, containing 0.1% gelatin and 0.02% NaN 3 ) for 30 min at 37uC. Lysis was stopped by adding 1 mL of cold GVB containing 10 mM EDTA. After being centrifuged at 4,4006g for 10 min at 4uC, the amount of hemoglobin released into the supernatant was measured at 412 nm, and the percent lysis relative to the number of cells lysed completely by water was calculated.
rTs-Pmy binding to C8 and C9
To determine whether rTs-Pmy binds to C8 and C9,purified human C8,C9 (Merck,Germany) and non-relevant control BSA (Sigma,USA) (1 mg each) were subjected to SDS-PAGE under reducing conditions and transferred to a PVDF membrane. After blocking with 5% milk in TBS-T, the membrane was incubated with 10 mL of rTs-Pmy (5 mg/mL in TBS-T) for 3 hours at 37uC and then with mAb 7E2 (50 ng/mL) for 1 hour at room temperature. Peroxidase-conjugated goat anti-mouse IgG (1:4,000; Sigma,USA) was used as the secondary antibody. Bands were visualized with ECL (Pierce,USA). To determine the specific binding of Ts-Pmy to C8 and C9, rTs-87 was used as a control to react with C8 and C9 that had been transferred to a PVDF membrane and probed with anti-Ts87 antiserum. For the reciprocal experiment, the same amount of rTs-Pmy and BSA (1 mg ) was transferred to a PVDF membrane and incubated with C9 (0.5 mg/mL) for 2 hours at 37uC. After being washed with TBS-T, the membrane was incubated with monoclonal anti-C9 antibody (1:4,000; Abcam, USA). To determine the competition between the soluble C9 and blotted C9 for binding to Ts-Pmy, rTs-Pmy was pre-incubated with C9 1:6 (w/w, 5 mg/mL of rTsPmy and 30 mg/mL of C9) for 1 hour at 37uC before being incubated with the membrane. The membrane was then reacted with mAb 7E2 (50 ng/mL) and IRDye-800CW-conjugated goat anti-mouse IgG (1:10,000; LI-COR, Germany).
C9 polymerization assays
To determine the effect of rTs-Pmy on Zn
2+
-activated C9 polymerization [30] , 3 mg of C9 was pre-incubated with various amounts of rTs-Pmy at 37uC for 40 min and incubated with 50 mM ZnCl 2 in 20 mM Tris buffer, pH 7.2 for 2 hours at 37uC. Inhibition of C9 polymerization was shown by SDS-PAGE on a 2.5 to 25% acrylamide gradient gel under reducing conditions; the gel was visualized by staining with Coomassie blue [31] or analyzed by western blot with an anti-C9 antibody. A non-relevant T. spiralis antigen Ts87 was used as a control.
rTs-Pmy inhibition of C9 polymerization on E R was performed as reported by Tschopp et al. [32] . One hundred microliters of normal human serum (NHS) supplemented with 5 mg of C9 was pre-incubated with 30 mg of rTs-Pmy for 40 min at 37uC prior to the addition of 3610 6 E R and continued incubation for 1 hour at 37uC. Lysed cells were washed three times with 3 mL of TBS containing 5 mM EDTA (pH 8.0) and centrifuged for 20 min at 4,8006g at 4uC. Sediments were washed three times with 3 mL of 0.5 mM PBS (pH 8.0). Lysed cell pellets were analyzed by SDS-PAGE under reducing conditions on a 2.5 to 15% gradient acrylamide gel followed by either Coomassie blue staining or Western blot with an anti-C9 antibody.
Statistical analysis
Results were expressed as the mean 6 SD. Differences between groups were assessed by SPSS 10.0 (SPSS Inc., USA) using OneWay ANOVA; p,0.05 was considered to be statistically significant.
Results
Expression and localization of Ts-Pmy in different developmental stages of T. spiralis
The transcription of Ts-Pmy mRNA at different developmental stages in T. spriralis was analyzed by RT-PCR with Ts-Pmy specific primers. Ts-Pmy mRNA was transcribed in all developmental stages (ML, NBL and adult worm; Figure 1A ). The size of the amplified cDNA fragments was 900 bp, which is the same size as predicted by the DNA sequence. Western blot analysis showed that an approximately 100 kDa band was recognized by mAb 7E2 in the somatic extracts the three developmental stages of T. spiralis (ML, adult and NBL) ( Figure 1B) . The results show that Ts-Pmy is expressed in all three developmental stages (ML, adult worm and NBL) of T. spiralis at the level of both mRNA transcription and protein expression. Previously, immunofluorescent staining of worm sections demonstrated that Ts-Pmy was expressed on the surface of T. spiralis larvae [23] . Here, immunoelectron microscopy confirmed that Ts-Pmy was expressed on the outer membrane of the cuticle of the NBL (Figure 1Ca ) and adult worm (Figure 1Cb ). No significant staining was observed using normal mouse serum at the same dilution (c and d). Using immunofluorescence staining, Ts-Pmy was also observed on the surface of intact adult worms (Figure 1Da ) and NBL (Figure 1Db ).
Enhanced complement-mediated killing of NBL treated with anti-rTs-Pmy rabbit serum
To determine whether Ts-Pmy expressed on the parasite surface protects NBL from being killed by the host complement, heatinactivated rabbit anti-rTs-Pmy serum was used to block Ts-Pmy on the NBL. The antiserum-or normal rabbit serum-treated NBL were challenged with the complement from fresh NGS. As shown in Figure 2 , after being blocked with anti-rTs-Pmy serum, NBL viability was significantly decreased following incubation with fresh NGS compared to those of the normal rabbit serum group. The increase in complement-mediated killing of NBL blocked with anti-rTs-Pmy serum was observed in an antiserum dose-dependent manner. After being absorbed with rTs-Pmy, the anti-rTs-Pmy serum had a minimal or non-existent effect on the complementmediated NBL killing. Incubating with rabbit antiserum against recombinant Ts87, a specific T. spiralis secreted protein [33] , that is also located on the surface of worm [34] , did not significantly increase complement-mediated NBL killing (Figure 2 ).
In vivo decrease in the infectivity of NBL treated with anti-rTs-Pmy rabbit serum and complement
The number of ML recovered from mouse muscle was reduced by 95.1% for those NBL treated with anti-rTs-Pmy rabbit serum and NGS complement compared with those treated with normal rabbit serum/NGS 26 days after being transferred intravenously into mice (Figure 3 ; p = 0.006) . No significant reduction was observed for ML developed from NBL treated with rTs-Pmy preabsorbed anti-rTs-Pmy serum. Heat-inactivated NGS (INGS) had a smaller killing effect on NBL treated with anti-rTs-Pmy rabbit serum (72.0% ML reduction) or with the same serum preabsorbed with rTs-Pmy (48.5% ML reduction) compared with the normal rabbit serum control (Figure 3 ; p = 0.048). These studies further indicated that Ts-Pmy on the surface of NBL may protect larvae from complement-mediated killing.
Inhibition of complement-mediated hemolysis by rTsPmy
Complement-mediated E R lysis via the alternative pathway was significantly inhibited by adding rTs-Pmy in a dose-dependent manner (p,0.001). E R lysis was reduced by 55.7% when 10 mg of rTs-Pmy was added and by 91.9% when 40 mg of rTs-Pmy was added (Figure 4) . Figure 2 . Enhanced complement-mediated killing of T. spiralis NBL incubated with anti-rTs-Pmy rabbit serum. NBL were incubated with different amounts of anti-rTs-Pmy rabbit serum, the same serum pre-absorbed with rTs-Pmy or normal rabbit serum (NRS) in a total volume of 50 mL for 60 min before adding fresh normal guinea pig serum (NGS). In addition, 40 mL of anti-Ts87 rabbit serum was used as a control. Viability of NBL was observed under an inverted microscope. Values are expressed as the means 6 SD for three independent experiments. *, statistically significant differences (p,0.05) between anti-rTs-Pmy and anti-rTs-Pmy + rTs-Pmy or NGS control. doi:10.1371/journal.pntd.0001225.g002 Figure 3 . Recovered ML developed from NBL treated with antirTs-Pmy rabbit serum and NGS. Two thousand NBL were incubated with anti-rTs-Pmy rabbit serum, the same serum absorbed with rTs-Pmy or NRS (100 mL), followed by NGS or INGS. Treated NBL were then injected into BALB/c mice. ML were recovered from the muscle tissues of mice 26 days after injection. Data represent the means 6 SD from three independent experiments. **, indicate statistically significant differences (p,0.01) between the antiserum-treated/NGS group and protein absorbed serum/NGS or NRS/NGS group; * indicate statistically significant differences (p = 0.048) between the antiserum-treated/INGS group and NRS/INGS group (n = 8 in each group). doi:10.1371/journal.pntd.0001225.g003 
Binding of rTs-Pmy to human C8 and C9
After being transferred to a membrane, the human C8 and C9 were probed with rTs-Pmy and detected with anti-rTs-Pmy mAb. Western blot analysis demonstrated that rTs-Pmy strongly bound to human C8 (a,b chains) and C9 ( Figure 5B ). The amount of rTsPmy bound to the immobilized C9 was dramatically decreased ( Figure 5E ) after being absorbed with soluble C9. Reciprocally, the binding of C9 to rTs-Pmy immobilized on a membrane was also demonstrated by incubating the membrane with soluble C9 and detecting with an anti-C9 mAb (Figure 6 ). In the control experiment, the same amount of recombinant Ts87 did not bind to C8 and C9 ( Figure 5D ).
6. Inhibition of C9 polymerization and poly-C9 formation on the E R by rTs-Pmy C9 polymerization leads to the creation of transmembrane channels that are critical for complement-mediated cytolysis [35] . To determine whether Ts-Pmy inhibits the Zn 2+ -induced C9 polymerization, C9 was mixed with various amounts of rTs-Pmy and then incubated with 50 mM ZnCl 2 . As shown in Figure 7 , rTsPmy inhibited Zn 2+ -induced C9 polymerization in a dosedependent manner. When the amount of rTs-Pmy was increased to 10 mg, it completely inhibited the polymerization of 3 mg of C9 (Figure 7, lane 6) . The same amount of recombinant Ts87 did not inhibit C9 polymerization. In addition, rTs-Pmy inhibited the Figure 5 . Determination of rTs-Pmy binding to human C8 and C9. Human C8 (1 mg, Lane 1) and C9 (1 mg, Lane 3) and non-relevant BSA control (1 mg, Lane 2) were subjected to SDS-PAGE under reducing conditions and (A) stained with Coomassie blue, and then (B) transferred onto a PVDF membrane, incubated with rTs-Pmy (5 mg/mL) and detected with anti-rTs-Pmy mAb (50 ng/mL). The same materials that were added, plus nonrelevant control protein rTs87 (300 ng; Lane 4) were subjected to SDS-PAGE and (C) stained with Coomassie blue, and (D) transferred to an NC membrane, incubated with rTs87 (5 mg/mL) and detected with anti-Ts87 rabbit serum (1:4000). To determine the binding competition between soluble and immobilized C9 to rTs-Pmy, rTs-Pmy (5 mg/mL) was pre-incubated with C9 (30 mg/mL) for 1 hour before incubation with the membrane containing with C9 (1 mg) and BSA (1 mg), and was detected with anti-rTs-Pmy mAb (50 ng/mL) (E). M:standard protein marker. doi:10.1371/journal.pntd.0001225.g005 
Discussion
Recent studies have shown that the complement system plays a role in granulocyte recruitment and parasite impairment in nematode infection prior to antibody production [36] . Complement components have been implicated in the killing of Strongyloides stercoralis larvae [37] and Schistosoma mansoni schistosomula [21] . The ability to evade complement attack is essential for the survival of tissue-dwelling nematodes within hosts. Many parasites, especially those living in or in contact with blood, seem to have developed parallel routes to escape complement attack [38] . T. spiralis infective larvae (ML), adults and NBL are able to bind to the complement components [14] and evade complement-mediated killing [15] . However, the mechanism by which T. spiralis evades complementmediated killing is still not completely understood.
Paramyosin is an essential muscle protein in invertebrates, forming the core of thick myofilaments that determine the length and stability of muscles [17] . It has been suggested that the surface expression of paramyosin by Schistosoma mansoni [20] and Taenia solium [39] may inhibit the complement cascade of the immune system. Thus, in the present study, we examined the expression and localization of Ts-Pmy in the three developmental stages of T. spiralis and showed that Ts-Pmy is present on the outer membrane of the cuticle of the adults and NBL of T. spiralis. Our results were consistent with other observations that identified paramyosin in the tegument and on the surface of Schistosoma mansoni, Schistosoma japonicum [19] , Echinococcus granulosus [40] , Taenia solium [39] and Fasciola hepatica [41] . The existence of a surface-exposed form of paramyosin suggests a role as a potential modulator of the host immune system. It was previously observed that paramyosin on the surface of helminth parasites bound to the Fc of IgG [19] and IgA [42] , collagen and at least three complement components, C1q [18] , C8 and C9 [20] . The fact that Ts-Pmy is expressed on Our data confirmed that surface-exposed Ts-Pmy binds to complement C8 and C9, which are important components of the complement activation cascade and comprise the membrane attack complex (MAC) [43] . Polymerization of C9 induced by Zn 2+ was highly inhibited by rTs-Pmy, indicating that the assembly of the MAC was impaired. The alternative complement pathway that activates the complement complex or poly-C9 on the rabbit erythrocytes (E R ) was also greatly inhibited by rTs-Pmy. These studies suggest that Ts-Pmy binding to C8 and C9 inhibits the assembly and formation of the MAC, creating an effective strategy for the parasite to evade complement attack [28] . Similar strategies are also adopted by Schistosoma mansoni [28] , Entamoeba hisolytica [44] , Herpesvirus saimiri [45] and Trypanosoma cruzi [46] . Functional analysis in this study revealed that rTs-Pmy inhibited the lysis of E R triggered by guinea pig serum, indicating that the binding of Ts-Pmy to C8/C9 or other complement elements inhibits the complement activation pathways. Whole T. spiralis worms also inhibited of complement-mediated hemolysis [14] , suggesting that native Ts-Pmy or other modulating molecules on the surface of the worm might have similar functions as complement inhibitors. Such observations are consistent with the findings of other studies of paramyosin in Schistosoma mansoni [20, 21] .
Additional evidences from this study show that native Ts-Pmy on the surface of T. spiralis effectively protected NBL from attack by host complements. Blocking Ts-Pmy on the surface of T. spiralis with anti-rTs-Pmy antiserum reduce of NBL viability when under attack by complement in vitro. In vivo passive transfer experiments with NBL treated with anti-Ts-Pmy antiserum and NGS also showed a significant reduction in the number of NBL that developed into ML in mouse muscle, indicating that the infectivity of these larvae after Ts-Pmy blocked by antibodies was seriously impaired.
Our studies suggest that the outer membrane form of paramyosin expressed by T. spiralis has a role in host immunomodulation, presumably by inhibiting the formation of the MAC and thereby protecting the parasite from being damaged by activated complement. This modulation is an effective survival strategy for T. spiralis to live within its host. Disruptions of the immunomodulatory function of Ts-Pmy could be explored as an alternative strategy to control T. spiralis infection. As a result, T. spiralis paramyosin is under further evaluation as a potential laboratory reagent to study host complement function and as a potential vaccine antigen. The specific epitope in Ts-Pmy that reacts with the complement or elicits protective immunity is currently being defined.
